Academic Journal
Continuous vs intermittent adenosine 2A receptor (A2AR) inhibition in preclinical colon cancer (CC) models and in a Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with non-small cell lung cancer (NSCLC)
| العنوان: | Continuous vs intermittent adenosine 2A receptor (A2AR) inhibition in preclinical colon cancer (CC) models and in a Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with non-small cell lung cancer (NSCLC) |
|---|---|
| المؤلفون: | Lin, C.C., Joerger, M., Grell, P., Chiappori, A.A., Leal, T.A., Kasper, S., Jerusalem, G., Gonçalves, A., Wolf, J., De Braud, F., de Jonge, M.J.A., Otero, J., Chhagan, S., Cipolletta, D., Morris, E., Chowdhury, N.R., Hurtado, F.K., Tan, D.S. |
| المساهمون: | Roche |
| المصدر: | European Journal of Cancer ; volume 138, page S12-S13 ; ISSN 0959-8049 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/s0959-8049(20)31098-4 |
| الاتاحة: | http://dx.doi.org/10.1016/s0959-8049(20)31098-4 https://api.elsevier.com/content/article/PII:S0959804920310984?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0959804920310984?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
| رقم الانضمام: | edsbas.9D24B141 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/s0959-8049(20)31098-4 |
|---|